retatrutide heart arrhythmia Rate Increase: Mechanism, Evidence, and Clinical Guidance – Bolt Pharmacy Arrhythmia : Carolina Primary Care

GHK-CU GHK-Cu is a naturally occurring tripeptide-copper complex, originally isolated from human plasma

Both surgery and GLP-1s are part of a continuum of treatments for obesity

Cardiometabolic benefits Both tirzepatide and retatrutide have demonstrated improvements in various cardiometabolic risk factors, such as blood pressure, lipid profiles, and glycemic control

therefore, substantial weight reduction may naturally raise endogenous testosterone, potentially requiring dose adjustments in those on testosterone replacement therapy (TRT)

Need broader context on combining peptides

In June 2021, this groundbreaking medication Wegovy was approved by the FDA for weight management in adults with obesity or overweight with 1 weight-related comorbidity (such as hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease.) Then the question remained , what happens after 68 weeks